Asthma and autoimmunity: a complex but intriguing relation. (Q51676365)

9 April 2018

title

Asthma and autoimmunity: a complex but intriguing relation. (English)

1 reference

9 April 2018

1 reference

Alberto Tedeschi

1

1 reference

9 April 2018

Riccardo Asero

series ordinal

2

1 reference

9 April 2018

publication date

1 November 2008

1 reference

9 April 2018

Expert Review of Clinical Immunology

published in

1 reference

9 April 2018

volume

4

1 reference

9 April 2018

page(s)

767-776

1 reference

9 April 2018

issue

6

1 reference

9 April 2018

Relation between occurrence of type 1 diabetes and asthma

cites work

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

The effect of infections on susceptibility to autoimmune and allergic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Allergy and allergic diseases. First of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Allergy and allergic diseases. Second of two parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Allergic vs nonallergic asthma: what makes the difference?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Coincidence of immune-mediated diseases driven by Th1 and Th2 subsets suggests a common aetiology. A population-based study using computerized general practice data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Geographic variation of MS incidence in two prospective studies of US women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Hay fever, hygiene, and household size

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Atopic versus infectious diseases in childhood: a question of balance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Role of regulatory T cells in human diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Coexistence of IgE-mediated allergy and type 1 diabetes in childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

There is no evidence of an inverse relationship between TH2-mediated atopy and TH1-mediated autoimmune disorders: Lack of support for the hygiene hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Bronchial reactivity and airflow obstruction in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Bronchial hyperreactivity in systemic sclerosis patients: influence of associated Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Inflammation and structural changes in the airways of patients with primary Sjögren's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

The continuing enigma of non-atopic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Staphylococcus aureus enterotoxins: a key in airway disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

The Development of Respiratory Syncytial Virus-Specific IgE and the Release of Histamine in Nasopharyngeal Secretions after Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Respiratory infections: their role in airway responsiveness and the pathogenesis of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Chlamydophila (Chlamydia) pneumoniae serology and asthma in adults: a longitudinal analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Autoantibodies to β2-Adrenergic Receptors: a Possible Cause of Adrenergic Hyporesponsiveness in Allergic Rhinitis and Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Novel clinical and serological aspects in non-allergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Identification of cytokeratin 18 as a bronchial epithelial autoantigen associated with nonallergic asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Identification of alpha-enolase as an autoantigen associated with severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

T and B cell immune response to a 55-kDa endothelial cell-derived antigen in severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Autologous serum skin test reactivity in patients with non-allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Thrombin functions as an inflammatory mediator through activation of its receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Autologous serum skin test for autoantibodies is associated with airway hyperresponsiveness in patients with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Asthma as a paradigm for autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Targeting airway inflammation in asthma: current and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Effect of omalizumab on patients with chronic urticaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Effect of anti-IgE therapy in patients with peanut allergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

New drugs targeting Th2 lymphocytes in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Evidence of a role of tumor necrosis factor alpha in refractory asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Targeting TNF-alpha: a novel therapeutic approach for asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Understanding the pathophysiology of severe asthma to generate new therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Local expression of ϵ germline gene transcripts and RNA for the ϵ heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Class switch recombination to IgE in the bronchial mucosa of atopic and nonatopic patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F1744666X.4.6.767

21 January 2018

Identifiers

DOI

10.1586/1744666X.4.6.767

1 reference

9 April 2018

PubMed ID

20477126

1 reference

9 April 2018